Publications

2021

Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase‐3

Physiological Reports.9(5):-[DOI] 10.14814/phy2.14766.[PMID] 33713581.

6 citations·PubMed·Publisher's Site

2021

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

Nature Reviews Nephrology.17(5):319-334[DOI] 10.1038/s41581-021-00393-8.[PMID] .

PubMed·Publisher's Site

2020

Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.

American journal of physiology. Renal physiology.318(2):F509-F517[DOI] 10.1152/ajprenal.00518.2019.[PMID] 31904280.

9 citations·PubMed·Publisher's Site

2020

Selective inhibition of arginase-2 in endothelial cells but not proximal tubules reduces renal fibrosis

JCI Insight.5(19):-[DOI] 10.1172/jci.insight.142187.[PMID] 32956070.

6 citations·PubMed·Publisher's Site

2019

l ‐Homoarginine supplementation prevents diabetic kidney damage

Physiological Reports.7(18):-[DOI] 10.14814/phy2.14235.[PMID] 31552707.

12 citations·PubMed·Publisher's Site

2017

Arginase-2 mediates renal ischemia-reperfusion injury.

American journal of physiology. Renal physiology.313(2):F522-F534[DOI] 10.1152/ajprenal.00620.2016.[PMID] 28515179.

9 citations·PubMed·Publisher's Site

2017

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

American journal of physiology. Renal physiology.313(4):F899-F905[DOI] 10.1152/ajprenal.00158.2017.[PMID] 28446459.

6 citations·PubMed·Publisher's Site

2017

Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.

Kidney international.91(3):671-682[DOI] 10.1016/j.kint.2016.09.042.[PMID] 27914709.

21 citations·PubMed·Publisher's Site

2015

Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.

American journal of physiology. Renal physiology.309(5):F447-55[DOI] 10.1152/ajprenal.00137.2015.[PMID] 26041444.

22 citations·PubMed·Publisher's Site

2015

Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.

PloS one.10(7):e0133777-[DOI] 10.1371/journal.pone.0133777.[PMID] 26207369.

9 citations·PubMed·Publisher's Site

2015

Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.

Kidney international.88(4):722-33[DOI] 10.1038/ki.2015.162.[PMID] 26061548.

115 citations·PubMed·Publisher's Site

2015

Tissue Distribution, Excretion and Pharmacokinetics of the Environmental Pollutant Dibenzo[def,p]chrysene in Mice.

Chemical research in toxicology.28(7):1427-33[DOI] 10.1021/acs.chemrestox.5b00097.[PMID] 26034881.

11 citations·PubMed·Publisher's Site

2014

Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.

American journal of physiology. Renal physiology.307(11):F1292-301[DOI] 10.1152/ajprenal.00176.2014.[PMID] 25320354.

26 citations·PubMed·Publisher's Site

2013

Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.

Kidney international.84(6):1189-97[DOI] 10.1038/ki.2013.215.[PMID] 23760286.

40 citations·PubMed·Publisher's Site

2013

Macrophages directly mediate diabetic renal injury.

American journal of physiology. Renal physiology.305(12):F1719-27[DOI] 10.1152/ajprenal.00141.2013.[PMID] 24173355.

98 citations·PubMed·Publisher's Site

2013

Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.

American journal of physiology. Renal physiology.305(6):F891-900[DOI] 10.1152/ajprenal.00149.2013.[PMID] 23884140.

20 citations·PubMed·Publisher's Site

2012

Management of Diabetic Nephropathy in the Elderly: Special Considerations.

Journal of nephrology & therapeutics.2(5):-[DOI] .[PMID] 24010011.

2 citations·PubMed·Publisher's Site

2012

Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.

Open journal of nephrology.2(2):5-18[DOI] .[PMID] 23293752.

11 citations·PubMed·Publisher's Site

2012

Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Journal of general internal medicine.27(4):458-68[DOI] 10.1007/s11606-011-1912-5.[PMID] 22005942.

41 citations·PubMed·Publisher's Site

2011

Arginase-2 mediates diabetic renal injury.

Diabetes.60(11):3015-22[DOI] 10.2337/db11-0901.[PMID] 21926276.

68 citations·PubMed·Publisher's Site

2011

Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.

Kidney international.79(10):1090-8[DOI] 10.1038/ki.2010.544.[PMID] 21289599.

64 citations·PubMed·Publisher's Site

2011

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.

American journal of physiology. Renal physiology.301(6):F1358-66[DOI] 10.1152/ajprenal.00332.2011.[PMID] 21880831.

82 citations·PubMed·Publisher's Site

2009

Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury.

Kidney international.75(7):689-98[DOI] 10.1038/ki.2008.648.[PMID] 19129795.

165 citations·PubMed·Publisher's Site

2009

Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.

Kidney international.75(2):167-75[DOI] 10.1038/ki.2008.400.[PMID] 18971925.

64 citations·PubMed·Publisher's Site

2008

Activation of adenosine 2A receptors preserves structure and function of podocytes.

Journal of the American Society of Nephrology : JASN.19(1):59-68[DOI] .[PMID] 18045850.

46 citations·PubMed·Publisher's Site

2008

Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Kidney international.73(11):1220-30[DOI] 10.1038/ki.2008.34.[PMID] 18322542.

63 citations·PubMed·Publisher's Site

2007

Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition.

Journal of immunology (Baltimore, Md. : 1950).178(7):4240-9[DOI] .[PMID] 17371980.

103 citations·PubMed·Publisher's Site

2007

Distant organ injury following acute kidney injury.

American journal of physiology. Renal physiology.293(1):F28-9[DOI] .[PMID] 17429033.

22 citations·PubMed·Publisher's Site

2007

Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury.

American journal of physiology. Lung cellular and molecular physiology.293(1):L105-13[DOI] .[PMID] 17416740.

90 citations·PubMed·Publisher's Site

2006

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.

American journal of physiology. Renal physiology.290(4):F828-37[DOI] .[PMID] 16332931.

120 citations·PubMed·Publisher's Site

2006

Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.

American journal of physiology. Renal physiology.290(6):F1516-24[DOI] .[PMID] 16403835.

183 citations·PubMed·Publisher's Site

2005

Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.

American journal of hypertension.18(4 Pt 1):544-8[DOI] .[PMID] 15831366.

12 citations·PubMed·Publisher's Site

2004

Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.

Journal of hypertension.22(8):1571-7[DOI] .[PMID] 15257181.

27 citations·PubMed·Publisher's Site

2003

The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats.

Endocrinology.144(6):2229-33[DOI] .[PMID] 12746279.

51 citations·PubMed·Publisher's Site

2003

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

Kidney international.64(4):1208-13[DOI] .[PMID] 12969138.

123 citations·PubMed·Publisher's Site

Show More